Beijing Quietly Charms Both MNCs And Specialty Biotechs In Effort To Establish China's Bio Valley
This article was originally published in The Pink Sheet Daily
Executive Summary
Dubbed the "G20 Project," the Beijing Leap-forward Development Program for Biopharmaceutical Industry seeks to transform the capital city into China's hub for biotech R&D and manufacturing.